Dr. Guangzhong Guo | Glioma | Best Researcher Award

Guangzhong Guo is a resident physician at Zhoukou Central Hospital and a master’s graduate of Zhengzhou University. Specializing in glioma and circulating tumor DNA (ctDNA), he has published four SCI papers and completed two research projects. His work focuses on using ctDNA for dynamic monitoring of glioma recurrence and progression. With expertise in oncological diagnostics and molecular pathology, he integrates research into clinical practice to enhance patient care. He has also contributed to consultancy and industry projects, further advancing neuro-oncology.

Dr. Guangzhong Guo | Zhengzhou University | China

🎓Education

Guangzhong Guo obtained his master’s degree from Zhengzhou University, where he focused on medical research related to glioma and circulating tumor DNA (ctDNA). His academic journey has been marked by a strong commitment to advancing cancer diagnostics and treatment strategies.

👨‍🏫Experience

Currently serving as a resident physician at Zhoukou Central Hospital, Guangzhong Guo applies his medical expertise in clinical settings, contributing to patient care and oncology research. His role involves diagnosing and treating glioma cases while integrating research findings into practical applications for improved patient outcomes.

🏆Awards and Recognitions

With a strong academic and clinical background, Guangzhong Guo has been actively involved in oncology research and has contributed to consultancy and industry projects. His dedication to advancing glioma treatment and diagnostics has earned him recognition within the medical research community.

💡Skills and Certifications

His core competencies include oncological diagnostics, molecular pathology, and clinical research methodologies. He is adept at analyzing ctDNA for glioma progression monitoring, integrating research insights into patient care, and contributing to innovative treatment approaches.

🔬 Research Focus

Guangzhong Guo’s primary research areas include glioma and ctDNA. His work on dynamic ctDNA monitoring offers precise insights into glioma recurrence patterns, enabling better treatment planning and personalized patient management. His commitment to bridging clinical practice with cutting-edge research continues to drive advancements in neuro-oncology.

🌎Conclusion

Guangzhong Guo is a highly deserving candidate for the Best Researcher Award due to his groundbreaking contributions to glioma research, commitment to scientific excellence, and impactful clinical applications. His work on ctDNA has the potential to revolutionize glioma diagnosis, recurrence prediction, and treatment monitoring, making him an invaluable asset to the field of neuro-oncology.

📖Publications

Dynamic Monitoring of Circulating Tumor DNA to Predict the Risk of Non In Situ Recurrence of Postoperative Glioma
Author: Guangzhong Guo et al.
Journal: Cancer Medicine
Dynamics of Tumor In Situ Fluid Circulating Tumor DNA in Recurrent Glioblastomas Forecasts Treatment Efficacy of Immune Checkpoint Blockade Coupled with Low-Dose Bevacizumab
Author: Guangzhong Guo et al.
Journal: Journal of Cancer Research and Clinical Oncology
Predicting Recurrent Glioblastoma Clinical Outcome to Immune Checkpoint Inhibition and Low-Dose Bevacizumab with Tumor In Situ Fluid Circulating Tumor DNA Analysis
Author: Guangzhong Guo et al.
Journal: Cancer Immunology, Immunotherapy
Tracking Tumor Evolution During the First-Line Treatment in Brain Glioma via Serial Profiling of Cell-Free Tumor DNA from Tumor In Situ Fluid
Author: Guangzhong Guo et al.
Journal: Frontiers in Oncology
Molecular and Clonal Evolution In Vivo Reveal a Common Pathway of Distant Relapse Gliomas
Author: Guangzhong Guo et al.
Journal: iScience

Guangzhong Guo | Glioma | Best Researcher Award